MIR210HG promotes breast cancer progression by IGF2BP1 mediated m6A modification.

Shi, Wenjing; Tang, Yongzhe; Lu, Jing; Zhuang, Yihui; Wang, Jie.

Afiliación

Shi W; Department of Breast Diseases, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Tang Y; Shanghai Key Laboratory of Embryo Original Diseases, Hengshan Rd. 910, Shanghai, 200030, China.
Lu J; Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany.
Zhuang Y; Shanghai Municipal Key Clinical Speciality, Shanghai, China.
Wang J; Department of Breast Diseases, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

Cell Biosci ; 12(1): 38, 2022 Mar 28.

Article en En | MEDLINE | ID: mdl-35346372